Consumer Health: Bladder Cancer Awareness

This content is courtesy of Mayo Clinic, the No. 1 hospital in the nation according to U.S. News & World Report. Minnesota Oncology is a member of the Mayo Clinic Care Network. This relationship provides us with access to information, knowledge and expertise from Mayo Clinic.

May is Bladder Cancer Awareness Month, which makes this a good time to learn more about bladder cancer.

Bladder cancer is one of the most common cancers. Nearly 84,000 new cases will be diagnosed in the U.S. in 2021, according to the American Cancer Society. Bladder cancer occurs in men more frequently than in women, and the risk increases with age, especially after 55. But bladder cancer can occur at any age.

Most bladder cancers are diagnosed at an early stage — when the cancer is highly treatable. But even early-stage bladder cancers can recur after successful treatment. For this reason, people with bladder cancer typically need follow-up tests for years after treatment to look for bladder cancer that recurs.

Bladder cancer signs and symptoms can include:

  • Blood in the urine, which can cause urine to appear bright red or brown, though sometimes the urine appears normal and blood is detected on a lab test.
  • Frequent urination.
  • Painful urination.
  • Back pain.

If you've been diagnosed with bladder cancer, your treatment will be based on the type, grade and stage of the cancer, as well as your overall health and preferences. Treatment can include surgery, chemotherapy, radiation therapy, immunotherapy or targeted drug therapy.

Share

Categories

Tags

Recent Posts

#
May 15, 2024

More than 5 million people in the United States will be diagnosed with skin cancer this year. It is the most common form of cancer in this country, but it is also one of the most preventable.

#
May 8, 2024

May is National Brain Cancer Awareness month, and Minnesota Oncology would like you to know the facts about brain cancer and brain tumors.

#
May 1, 2024

Bladder cancer is the fourth most common cancer diagnosed in men, and men are four times more likely than women to develop it.